Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Predicts Technology Will Revolutionize Genomics

Premium

CARLSBAD, Calif.--A new Invitrogen technology that can be used to rapidly clone and express genes will expedite functional validation to keep pace with strides being made in structural genomics and DNA chip-based expressional analysis, according to Invitrogen CEO Lyle Turner. The proprietary technology, amenable to any gene collection, was first tested using the yeast genome. Since October 1997, Invitrogen has cloned 6,000 and expressed 1,000 yeast genes.

Subsequently, Invitrogen launched GeneStorm expression-ready yeast clones, the first in a series of products designed to assist life science researchers design functional validation assays to be applied to drug discovery. The company said it expects to launch its first line of GeneStorm human expression-ready clones this spring.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.